Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | aryl hydrocarbon receptor | 0.005 | 0.0167 | 0.0167 |
Loa Loa (eye worm) | thymidylate synthase | 0.0821 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.1763 | 0.1763 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.033 | 0.3735 | 0.3734 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0156 | 0.1513 | 0.1402 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0129 | 0.0129 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.0129 | 0.0129 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0821 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0043 | 0.0072 | 0.1581 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0821 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.033 | 0.3735 | 1 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0073 | 0.0453 | 1 |
Echinococcus granulosus | geminin | 0.0175 | 0.1763 | 0.1763 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0391 | 0.4508 | 0.4248 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.1763 | 0.1763 |
Echinococcus multilocularis | geminin | 0.0175 | 0.1763 | 0.1763 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.033 | 0.3735 | 0.3734 |
Echinococcus granulosus | thymidylate synthase | 0.0821 | 1 | 1 |
Brugia malayi | PAS domain containing protein | 0.005 | 0.0167 | 0.0167 |
Schistosoma mansoni | single-minded | 0.005 | 0.0167 | 0.0167 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0073 | 0.0453 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0043 | 0.0072 | 0.1581 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0129 | 0.0129 |
Schistosoma mansoni | hypothetical protein | 0.0135 | 0.1242 | 0.1242 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.033 | 0.3735 | 1 |
Echinococcus multilocularis | thymidylate kinase | 0.0073 | 0.0453 | 0.0453 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0821 | 1 | 1 |
Brugia malayi | thymidylate kinase | 0.0073 | 0.0453 | 0.0453 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0043 | 0.0072 | 0.1581 |
Brugia malayi | hypoxia-induced factor 1 | 0.0156 | 0.1513 | 0.1513 |
Brugia malayi | hypothetical protein | 0.0391 | 0.4508 | 0.4508 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0821 | 1 | 1 |
Onchocerca volvulus | Putative thymidylate kinase | 0.0073 | 0.0453 | 0.0452 |
Echinococcus multilocularis | thymidylate synthase | 0.0821 | 1 | 1 |
Onchocerca volvulus | 0.0821 | 1 | 1 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0129 | 0.0129 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0821 | 1 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.033 | 0.3735 | 0.3437 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0129 | 0.0129 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0821 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0043 | 0.0072 | 0.1581 |
Giardia lamblia | CDC8 | 0.0073 | 0.0453 | 0.5 |
Mycobacterium ulcerans | thymidylate kinase | 0.0073 | 0.0453 | 0.0452 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0129 | 0.0129 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.033 | 0.3735 | 0.3437 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0043 | 0.0072 | 0.1581 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0391 | 0.4508 | 1 |
Echinococcus granulosus | thymidylate kinase | 0.0073 | 0.0453 | 0.0453 |
Mycobacterium ulcerans | thymidylate synthase | 0.0821 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0169 | 0.168 | 0.168 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0129 | 0.0129 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0391 | 0.4508 | 0.4248 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0821 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0821 | 1 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.033 | 0.3735 | 0.3734 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.168 | 0.1571 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0129 | 0.0129 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0821 | 1 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.033 | 0.3735 | 0.3437 |
Schistosoma mansoni | hypothetical protein | 0.0073 | 0.0453 | 0.0453 |
Loa Loa (eye worm) | thymidylate kinase | 0.0073 | 0.0453 | 0.0328 |
Schistosoma mansoni | thymidylate kinase | 0.0073 | 0.0453 | 0.0453 |
Trypanosoma brucei | RNA helicase, putative | 0.0135 | 0.1242 | 0.0827 |
Schistosoma mansoni | thymidylate kinase | 0.0073 | 0.0453 | 0.0453 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 4 ug ml-1 | Inhibition of radiolabeled C5a binding to its membrane bound C5a anaphylatoxin chemotactic receptor | ChEMBL. | No reference |
MPO release (functional) | = 0.3 ug ml-1 | Nonspecific degranulation of polymorho neutrophils as measured by myeloperoxidase (MPO) release in a whole functional cell assay | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.